A61K36/287

Method for extracting flavone aglycones in <i>chrysanthemum morifolium</i>, extract obtained thereby and anti-inflammatory pharmaceutical composition

A method for extracting flavone aglycones in Chrysanthemum morifolium is provided. The method includes: (a) immersing a Chrysanthemum morifolium raw material in water or an aqueous solution to perform an immersion procedure for 3.5 hours or more to obtain an immersion sample; and (b) adding an extraction solvent to the immersion sample to perform an extraction procedure 5-60 minutes to obtain an extract. The Chrysanthemum morifolium raw material includes at least one of the following parts of Chrysanthemum morifolium: whole plant, roots, stems, leaves and flowers.

Method for extracting flavone aglycones in <i>chrysanthemum morifolium</i>, extract obtained thereby and anti-inflammatory pharmaceutical composition

A method for extracting flavone aglycones in Chrysanthemum morifolium is provided. The method includes: (a) immersing a Chrysanthemum morifolium raw material in water or an aqueous solution to perform an immersion procedure for 3.5 hours or more to obtain an immersion sample; and (b) adding an extraction solvent to the immersion sample to perform an extraction procedure 5-60 minutes to obtain an extract. The Chrysanthemum morifolium raw material includes at least one of the following parts of Chrysanthemum morifolium: whole plant, roots, stems, leaves and flowers.

Hemostatic preparation containing an extract of golden moss
10022410 · 2018-07-17 · ·

The present invention relates generally to agents and devices for promoting hemostasis and, more particularly, to an extract of a plant-based Traditional Chinese Medicinal product and devices incorporating such agents for the delivery thereof to bleeding wounds.

Hemostatic preparation containing an extract of golden moss
10022410 · 2018-07-17 · ·

The present invention relates generally to agents and devices for promoting hemostasis and, more particularly, to an extract of a plant-based Traditional Chinese Medicinal product and devices incorporating such agents for the delivery thereof to bleeding wounds.

Hemostatic preparation containing an extract of golden moss
10022410 · 2018-07-17 · ·

The present invention relates generally to agents and devices for promoting hemostasis and, more particularly, to an extract of a plant-based Traditional Chinese Medicinal product and devices incorporating such agents for the delivery thereof to bleeding wounds.

Hemostatic preparation containing an extract of golden moss
10022411 · 2018-07-17 · ·

The present invention relates generally to agents and devices for promoting hemostasis and, more particularly, to an extract of a plant-based Traditional Chinese Medicinal product and devices incorporating such agents for the delivery thereof to bleeding wounds.

Hemostatic preparation containing an extract of golden moss
10022411 · 2018-07-17 · ·

The present invention relates generally to agents and devices for promoting hemostasis and, more particularly, to an extract of a plant-based Traditional Chinese Medicinal product and devices incorporating such agents for the delivery thereof to bleeding wounds.

Hemostatic preparation containing an extract of golden moss
10022411 · 2018-07-17 · ·

The present invention relates generally to agents and devices for promoting hemostasis and, more particularly, to an extract of a plant-based Traditional Chinese Medicinal product and devices incorporating such agents for the delivery thereof to bleeding wounds.

Compositions and methods for treating diabetes, fatty liver, cardiopathies, insulin resistance, carbohydrate and fat metabolism

This disclosure provides compositions formulated in the form of tablets, wafer capsules, gel capsules, sticks, sachets, vials, droppers or in injectable form. The compositions comprise a mixture of: an extract of Chrysanthellum indicum, an extract of Cynara scolymus, an extract of Vaccinium myrtillus, an extract of Olea europaea, and pipeline. This disclosure also provides methods of treating pathological disorders of carbohydrate and/or fat metabolism in a patient by administering to the patient the compositions.

Compositions and methods for treating diabetes, fatty liver, cardiopathies, insulin resistance, carbohydrate and fat metabolism

This disclosure provides compositions formulated in the form of tablets, wafer capsules, gel capsules, sticks, sachets, vials, droppers or in injectable form. The compositions comprise a mixture of: an extract of Chrysanthellum indicum, an extract of Cynara scolymus, an extract of Vaccinium myrtillus, an extract of Olea europaea, and pipeline. This disclosure also provides methods of treating pathological disorders of carbohydrate and/or fat metabolism in a patient by administering to the patient the compositions.